Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Diagnostic Potential of Tear Proteins in Breast, Ovarian, Prostate, Melanoma, Pancreatic, and Colon Cancer

NCT05223218 is registered in ClinicalTrials.gov with Namida Lab as lead sponsor.

NCT NCT05223218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05223218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Diagnostic Potential of Tear Proteins in Breast, Ovarian, Prostate, Melanoma, Pancreatic, and Colon Cancer
Lead sponsor
Namida Lab
Phase
Observational
Overall status
Unknown status
Start date
August 25, 2021
Completion date
December 31, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer